Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s636, 2025. DOI: 10.25251/57ey8s02. Disponível em: https://skin.dermsquared.com/skin/article/view/3800. Acesso em: 25 may. 2026.